SAADI RYAN H. (Chief Executive Officer) received a stock award from TEVOGEN BIO HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 2/16/2024ACC: 0001062993-24-003494
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2024
+118.44M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
118.44M acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+98.90M
Price / share
—
Trade value
—
% of position
New position
2/14/2024
0.00→98.90M
Common Stock
Direct
Shares
+19.35M
Price / share
—
Trade value
—
% of position
19.6%
2/14/2024
98.90M→118.25M
Common Stock
Indirect
Shares
+193.92K
Price / share
—
Trade value
—
% of position
New position
2/14/2024
0.00→193.92K
Total
Net shares
+118.44M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2024 | A · Award | +98.90M | — | — | New position | 0.00 | 98.90M |
| Common Stock Direct | 2/14/2024 | A · Award | +19.35M | — | — | 19.6% | 98.90M | 118.25M |
| Common Stock Indirect | 2/14/2024 | A · Award | +193.92K | — | — | New position | 0.00 | 193.92K |
| Total | +118.44M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported